SIRT5 and pancreatic ductal adenocarcinoma: More recently, Hu and co-workers studied the role of SIRT5 in pancreatic ductal adenocarcinoma (PDAC) and developed a small-molecule SIRT5 activator, MC3138 (13, Figure 5) [38].